Effect of alanine replacements in the M158-66 epitope on recognition by specific CTL. Reactivity of CTL clone, directed against the M158-66 epitope, with stimulator cells infected with wild type (WT) (B) or influenza virus A/NL/95-M1 G58A (C), L60A (D), G61A (E), F62A (F), V63A (G), T65A (H), or L66A (I) was determined by intracellular IFN-γ staining and flow cytometry. PE, phycoerythrin conjugate; FITC, fluorescein isothiocyanate. GILGFVFTL-peptide pulsed cells were included as a positive control (J). Untreated cells were used as a negative control (A). Indicated is the percentage IFN-γ-positive cells within the CD8+-T-cell population. The data are also presented as the number of IFN-γ-positive spots, as measured in an IFN-γ-specific ELISPOT assay (K). In addition, the percentage of specific lysis, as measured in chromium release assays, is shown (M). Effector cells were added at an effector/target cell ratio of 10, and specific lysis was calculated. A CTL clone specific for the NP418-426 epitope was used as a control (L, N). The recognition of A/NL/95-M1 I59A and F64A could not be tested, since these mutant viruses could not be propagated to sufficiently high titers (*). Data from representative experiments are shown.